Patient‐derived organoids for personalized gallbladder cancer modelling and drug screening - Yuan, Bo; Zhao, Xiaofang; Wang, Xiang; Liu, Erdong; Liu, Chunliang; Zong, Yali; Jiang, Youhai; Hou, Minghui; Chen, Yao; Chen, Lei; Zhang, Yongjie; Wang, Hongyang; et al. (Clinical and translational medicine, 2022)
Keywords: Adult; Aged; Aged, 80 and over; Cancer therapies; Clinical medicine; drug screening; Drug Screening Assays, Antitumor - methods; Drug Screening Assays, Antitumor - statistics & numerical data; Early Detection of Cancer - instrumentation; Early Detection of Cancer - methods; Early Detection of Cancer - statistics & numerical data; Exome Sequencing - methods; Exome Sequencing - statistics & numerical data; Female; Gallbladder; Gallbladder cancer; Gallbladder Neoplasms - diagnosis; Gallbladder Neoplasms - therapy; Gallstones; Gene expression; HDAC; Histology; Humans; Male; Middle Aged; Models, Biological; Mutation; organoids; Organoids - pathology; Patients; Precision Medicine - instrumentation; Precision Medicine - methods; Precision Medicine - statistics & numerical data; Surgery; United States--US; China; Germany; gallbladder cancer; drug screening; organoids; HDAC